Composition of Silmäasema's Shareholders' Nomination Board


Composition of Silmäasema's Shareholders' Nomination Board

Silmäasema Oyj                
Stock Exchange Release 
29 November 2018 at 9:00 a.m. EET

Silmäasema's Shareholders' Nomination Board consists of the representatives nominated by Silmäasema's three largest shareholders and in addition the Chairman of the Board of Directors. The shareholders with the right to nominate members representing shareholders to the Nomination Board are those three shareholders having the largest share of votes represented by all the shares in Silmäasema on the first workday of September preceding the Annual General Meeting based on the shareholder's register held by Euroclear Finland Ltd.

According to this, the following members have been nominated to Silmäasema's Nomination Board:

  • Juhana Kallio, Intera Partners
  • Patrick Lapveteläinen, Mandatum Life Insurance Company Limited
  • Timo Sallinen, Varma Mutual Pension Insurance Company
  • Jukka Hienonen, Chairman of the Board of Directors of Silmäasema Oyj

The Nomination Board shall elect amongst its members the Chairman.

The Nomination Board prepares to the Annual General Meeting proposals on the election and remuneration of the Board of Directors. The Nomination Board will forward its proposals to the Board of Directors of the Company by 31 January 2019.

Additional information

Chairman of the Board of Directors Jukka Hienonen, tel. +358 50 388 9670

SILMÄASEMA OYJ

Anu Kankkunen
Interim CEO, CFO

Tuukka Hirvonen
Head of Communications and Investor Relations

Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has over 150 stores and 14 eye clinics in Finland as well as ten stores in Estonia. The Silmäasema chain employs close to 1,000 eye healthcare professionals. Silmäasema's Group net sales were EUR 118.3 million in 2017 and adjusted EBITDA was EUR 11.8 million.

GlobeNewswire